PPAR-Mediated Toxicology and Applied Pharmacology

Area of Science:

• Toxicology
• Pharmacology
• Molecular Biology

Background:

• Peroxisome proliferator-activated receptors (PPARs) are nuclear hormone receptors targeted for treating various diseases.
• PPAR modulators, including fibrates and thiazolidinediones (TZDs), are approved drugs.
• PPARs exhibit complex roles in both causing and protecting against agent- and pollutant-induced toxicity.

Purpose of the Study:

• To critically review and synthesize current knowledge on PPAR-mediated toxicity and protective effects.
• To provide a systematic understanding of PPARs in toxicology and applied pharmacology.
• To inform the development of safer and more effective PPAR-targeting therapeutics.

Main Methods:

• Literature review and critical analysis of existing studies on PPARs and toxicity.
• Synthesis of findings on both detrimental and protective roles of PPARs.
• Evaluation of evidence linking PPAR activation to specific toxicological outcomes and protective mechanisms.

Main Results:

• PPARs are implicated in diverse toxicities, including multiple organ damage induced by various agents and pollutants.
• PPAR activation can also confer protective effects against certain toxic insults.
• The specific outcome (toxicity vs. protection) depends on the PPAR subtype, ligand, and context.

Conclusions:

• A comprehensive understanding of PPARs' dual role in toxicity is essential for drug development.
• Differentiating between toxic and protective effects will enable the optimization of PPAR-based therapies.
• Further research is needed to fully elucidate the mechanisms underlying PPAR-mediated toxicity and protection.